NCT07591389 Promoting Radon Testing Among Mothers of Young Children
| NCT ID | NCT07591389 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of North Dakota |
| Condition | Lung Cancer (Diagnosis) |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-04-10 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2026-04-10 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Radon is the second-leading cause of lung cancer after smoking and may contribute to other cancer deaths; children are especially vulnerable due to a larger lung surface area and higher respiratory rates. The goal of this research is to test the feasibility of the radon app to promote radon testing among mothers of children aged 4 or younger when they receive a free radon test kit.
Eligibility Criteria
Inclusion Criteria: * Participants are female mothers of children aged 4 and under. * Participants own a smartphone. * Children brought in for appointments are their biological or adoptive child. Exclusion Criteria: * Previous testing for radon within the past two (2) years. * The mother's child brought in for the appointment is over 4 years of age.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07591389 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Lung Cancer (Diagnosis). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07591389 currently recruiting?
Yes, NCT07591389 is actively recruiting participants. Contact the research team at soojung.kim@UND.edu for enrollment information.
Where is the NCT07591389 trial being conducted?
This trial is being conducted at Bismarck, United States, Minot, United States.
Who is sponsoring the NCT07591389 clinical trial?
NCT07591389 is sponsored by University of North Dakota. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.